These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term survival in multiple myeloma. Kyle RA N Engl J Med; 1983 Feb; 308(6):314-6. PubMed ID: 6823231 [No Abstract] [Full Text] [Related]
6. Evaluation and treatment of multiple myeloma and related disorders. Salmon SE Ariz Med; 1974 Sep; 31(9):660-3. PubMed ID: 4213094 [No Abstract] [Full Text] [Related]
8. The clinical and pathologic spectrum of multiple myeloma. Kapadia SB Compr Ther; 1984 Jan; 10(1):46-51. PubMed ID: 6362971 [No Abstract] [Full Text] [Related]
9. [Granulocytic sarcoma in acute non-lymphoblastic leukemia as the terminal phase of multiple myeloma under prolonged treatment with alkylating agents]. Bernardeschi P; Urbano U Haematologica; 1983; 68(5):684-8. PubMed ID: 6416948 [No Abstract] [Full Text] [Related]
10. [Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion]. Monconduit M; Le Loët X; Bernard JF; Menard JF; Grosbois B; Michaux JL; De Gramont A; Laporte JP; Najman A; Jouet JP Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):477-9. PubMed ID: 3616472 [No Abstract] [Full Text] [Related]
11. Prognostic factors and therapeutic results in multiple myeloma. Nagai M; Kitahara T; Minato K; Takenaka T; Konda C; Seki S; Shimoyama M Jpn J Clin Oncol; 1985 Sep; 15(3):505-15. PubMed ID: 4057632 [TBL] [Abstract][Full Text] [Related]
12. [The effect of alkylating cytostatics on the development of secondary malignant tumors]. Galajda P; Donner L Vnitr Lek; 1984 Aug; 30(8):756-63. PubMed ID: 6506498 [No Abstract] [Full Text] [Related]
13. Pleural involvement in multiple myeloma. Airoldi M; Fantasia R; Giorgetti A; Stefanetti C Haematologica; 1986; 71(1):56-9. PubMed ID: 3084359 [No Abstract] [Full Text] [Related]
14. Therapeutic progress--review XII. Treatment of multiple myeloma. Oakley JE; Franklin IM J Clin Hosp Pharm; 1984 Mar; 9(1):15-20. PubMed ID: 6371060 [No Abstract] [Full Text] [Related]
16. Pulmonary fibrosis in a myeloma patient on bortezomib treatment. A new severe adverse effect of a new drug. Duek A; Feldberg E; Haran M; Berrebi A Am J Hematol; 2007 Jun; 82(6):502-3. PubMed ID: 17301973 [No Abstract] [Full Text] [Related]
17. [Acute myeloproliferative syndrome after alkylating agent treatment in a case of multiple myeloma]. Gardella S; Cervantes F; Bladé J; Brugués R; Rozman C Med Clin (Barc); 1982 Sep 1-15; 79(4):185-8. PubMed ID: 7144293 [No Abstract] [Full Text] [Related]
18. [Chemotherapy of multiple myeloma]. Estape J; Antón I; Daniels M; Bladé J; Domingo A; Rubio D Sangre (Barc); 1984; 29(5):936-9. PubMed ID: 6523344 [No Abstract] [Full Text] [Related]